Coartem News
Most Popular Coartem Story
FDA panel backs Novartis malaria drug
Novartis has won the unanimous support of an FDA expert committee on the efficacy of its malaria drug Coartem, with only one holdout on the safety vote. Novartis has asked for the agency's approval Read more...
Latest Headlines
- December 4, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
